Landlocked developing countries (LLDCs) vs Zambia: Percentage of bloodstream infection due to Escherichia coli resistant
Landlocked developing countries (LLDCs)
74.2%
in 2022
Zambia
76.5%
in 2022
Landlocked developing countries (LLDCs) rank
3rd
Zambia rank
6th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Landlocked developing countries (LLDCs)
- Zambia
How they compare
Zambia currently reports 76.5% against 74.2% in Landlocked developing countries (LLDCs), a difference of 2.3%.
The two have swapped places 1 time across 6 shared years of data; in 2016 it was Landlocked developing countries (LLDCs) ahead.
Landlocked developing countries (LLDCs) ranks 3rd and Zambia ranks 6th of 16 groups.
Zambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Landlocked developing countries (LLDCs) | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 50.0% | 58.9% | 8.9% | Zambia |
| 2020s | 73.7% | 88.4% | 14.7% | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Landlocked developing countries (LLDCs) or Zambia?
- Zambia, at 76.5% against 74.2% in Landlocked developing countries (LLDCs) as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Landlocked developing countries (LLDCs) and Zambia?
- 2.3%, with Zambia ahead.
- How many years of comparable data are there for Landlocked developing countries (LLDCs) and Zambia?
- 6 years are reported by both, from 2016 to 2022.
- How do Landlocked developing countries (LLDCs) and Zambia rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Landlocked developing countries (LLDCs) ranks 3rd and Zambia ranks 6th of 16 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.